BlackRock’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-117,154
| Closed | -$368K | – | 5337 |
|
|
2020
Q4 | $368K | Hold |
117,154
| – | – | ﹤0.01% | 4312 |
|
|
2020
Q3 | $362K | Buy |
117,154
+2
| +0% | +$6 | ﹤0.01% | 4211 |
|
|
2020
Q2 | $545K | Hold |
117,152
| – | – | ﹤0.01% | 4104 |
|
|
2020
Q1 | $607K | Sell |
117,152
-1
| -0% | -$5 | ﹤0.01% | 3943 |
|
|
2019
Q4 | $586K | Hold |
117,153
| – | – | ﹤0.01% | 4069 |
|
|
2019
Q3 | $931K | Hold |
117,153
| – | – | ﹤0.01% | 3949 |
|
|
2019
Q2 | $849K | Hold |
117,153
| – | – | ﹤0.01% | 4000 |
|
|
2019
Q1 | $937K | Hold |
117,153
| – | – | ﹤0.01% | 3886 |
|
|
2018
Q4 | $937K | Hold |
117,153
| – | – | ﹤0.01% | 3867 |
|
|
2018
Q3 | $1.8M | Buy |
117,153
+1,318
| +1% | +$20.3K | ﹤0.01% | 3754 |
|
|
2018
Q2 | $1.03M | Hold |
115,835
| – | – | ﹤0.01% | 3861 |
|
|
2018
Q1 | $1.02M | Buy |
115,835
+83
| +0.1% | +$732 | ﹤0.01% | 3825 |
|
|
2017
Q4 | $1.18M | Hold |
115,752
| – | – | ﹤0.01% | 3803 |
|
|
2017
Q3 | $1.79M | Buy |
115,752
+107,760
| +1,348% | +$1.67M | ﹤0.01% | 3667 |
|
|
2017
Q2 | $71K | Sell |
7,992
-47
| -0.6% | -$418 | ﹤0.01% | 4399 |
|
|
2017
Q1 | $212K | Buy |
+8,039
| New | +$212K | ﹤0.01% | 4152 |
|